NCT00570479View on ClinicalTrials.gov

Prophylactic Anecortave Acetate in Patients With a Retisert Implant

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Uveitis, PosteriorGlaucoma
Interventions
DRUG

anecortave acetate

Patients will receive the specified dose of anecortave acetate every 4 months in an anterior juxtascleral depot injection

Trial Locations (1)

76012

Texas Retina Associates, Arlington

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Texas Retina Associates

OTHER

NCT00570479 - Prophylactic Anecortave Acetate in Patients With a Retisert Implant | Biotech Hunter | Biotech Hunter